- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/04 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
Patent holdings for IPC class C07D 243/04
Total number of patents in this class: 36
10-year publication summary
|
1
|
3
|
1
|
0
|
4
|
2
|
1
|
2
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4587 |
3 |
| Vitae Pharmaceuticals, Inc. | 94 |
3 |
| Washington University | 1675 |
3 |
| Bitop AG | 51 |
2 |
| Merck Sharp & Dohme LLC | 3748 |
2 |
| Bristol-myers Squibb Company | 4809 |
1 |
| The Regents of the University of California | 20366 |
1 |
| FUJIFILM Corporation | 30016 |
1 |
| The Board of Trustees of the University of Illinois | 2730 |
1 |
| Vertex Pharmaceuticals Incorporated | 1623 |
1 |
| Arizona Board of Regents on behalf of Arizona State University | 2782 |
1 |
| Blueprint Medicines Corporation | 240 |
1 |
| Calithera Biosciences, Inc. | 38 |
1 |
| Central Glass Company, Limited | 1282 |
1 |
| Cornell University | 3379 |
1 |
| Firmenich SA | 1724 |
1 |
| Heptares Therapeutics Limited | 73 |
1 |
| Huntsman Petrochemical LLC | 302 |
1 |
| Institute for Myeloma & Bone Cancer Research | 5 |
1 |
| Mitsubishi Tanabe Pharma Corporation | 543 |
1 |
| Other owners | 8 |